Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
18307 | 557 | 39.0 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
116 | 3 | MUTATION RESEARCH//TOXICOLOGY//CARCINOGENESIS | 70215 |
2474 | 2 | ABERRANT CRYPT FOCI//ANTINEOPLASTIC DRUGS//COLON CARCINOGENESIS | 3972 |
18307 | 1 | ABERRANT CRYPT FOCI//COLON CARCINOGENESIS//AZOXYMETHANE | 557 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ABERRANT CRYPT FOCI | authKW | 2543357 | 24% | 35% | 134 |
2 | COLON CARCINOGENESIS | authKW | 437656 | 8% | 17% | 46 |
3 | AZOXYMETHANE | authKW | 346368 | 7% | 15% | 41 |
4 | COLON CANC PREVENT PROGRAM | address | 315857 | 2% | 52% | 11 |
5 | BETA CATENIN ACCUMULATED CRYPTS | authKW | 298461 | 1% | 78% | 7 |
6 | ABERRANT CRYPTS | authKW | 255808 | 3% | 33% | 14 |
7 | MUCIN DEPLETED FOCI | authKW | 191863 | 1% | 50% | 7 |
8 | 1 2 DIMETHYLHYDRAZINE | authKW | 176848 | 4% | 15% | 22 |
9 | ABERRANT CRYPT FOCUS | authKW | 137045 | 1% | 50% | 5 |
10 | GRANULOCYTE MARKER PROTEIN | authKW | 123343 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 7824 | 61% | 0% | 338 |
2 | Toxicology | 469 | 9% | 0% | 52 |
3 | Nutrition & Dietetics | 371 | 7% | 0% | 41 |
4 | Gastroenterology & Hepatology | 347 | 8% | 0% | 46 |
5 | Pathology | 168 | 6% | 0% | 31 |
6 | Pharmacology & Pharmacy | 18 | 6% | 0% | 34 |
7 | Food Science & Technology | 15 | 3% | 0% | 17 |
8 | Integrative & Complementary Medicine | 12 | 1% | 0% | 4 |
9 | Anatomy & Morphology | 8 | 1% | 0% | 4 |
10 | Cell Biology | 6 | 4% | 0% | 22 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COLON CANC PREVENT PROGRAM | 315857 | 2% | 52% | 11 |
2 | S IR MED SURG B | 109640 | 0% | 100% | 2 |
3 | AMS POULTRY PROGRAM | 54820 | 0% | 100% | 1 |
4 | BIOCHEM CANC PREVENT | 54820 | 0% | 100% | 1 |
5 | BIOCHIM MED UNITE 419 | 54820 | 0% | 100% | 1 |
6 | CANC CHEMOPREVENT CONTROL | 54820 | 0% | 100% | 1 |
7 | CNPQ F ESP | 54820 | 0% | 100% | 1 |
8 | DBT ICT ENERGY BIOSCI CEB | 54820 | 0% | 100% | 1 |
9 | ENVIRONM HLTH SUSCEPTIBIL LINEBERGER CANC | 54820 | 0% | 100% | 1 |
10 | EPIDEMIOLOGY HLTH SCI | 54820 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARCINOGENESIS | 15897 | 10% | 1% | 58 |
2 | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 12683 | 4% | 1% | 25 |
3 | CANCER LETTERS | 10433 | 9% | 0% | 48 |
4 | CANCER RESEARCH | 3197 | 9% | 0% | 48 |
5 | JAPANESE JOURNAL OF CANCER RESEARCH | 2211 | 2% | 0% | 12 |
6 | CANCER PREVENTION RESEARCH | 1603 | 1% | 0% | 6 |
7 | MOLECULAR CARCINOGENESIS | 1589 | 2% | 0% | 9 |
8 | CANCER BIOCHEMISTRY BIOPHYSICS | 1338 | 1% | 1% | 3 |
9 | EUROPEAN JOURNAL OF CANCER PREVENTION | 793 | 1% | 0% | 5 |
10 | CANCER SCIENCE | 751 | 1% | 0% | 7 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ABERRANT CRYPT FOCI | 2543357 | 24% | 35% | 134 | Search ABERRANT+CRYPT+FOCI | Search ABERRANT+CRYPT+FOCI |
2 | COLON CARCINOGENESIS | 437656 | 8% | 17% | 46 | Search COLON+CARCINOGENESIS | Search COLON+CARCINOGENESIS |
3 | AZOXYMETHANE | 346368 | 7% | 15% | 41 | Search AZOXYMETHANE | Search AZOXYMETHANE |
4 | BETA CATENIN ACCUMULATED CRYPTS | 298461 | 1% | 78% | 7 | Search BETA+CATENIN+ACCUMULATED+CRYPTS | Search BETA+CATENIN+ACCUMULATED+CRYPTS |
5 | ABERRANT CRYPTS | 255808 | 3% | 33% | 14 | Search ABERRANT+CRYPTS | Search ABERRANT+CRYPTS |
6 | MUCIN DEPLETED FOCI | 191863 | 1% | 50% | 7 | Search MUCIN+DEPLETED+FOCI | Search MUCIN+DEPLETED+FOCI |
7 | 1 2 DIMETHYLHYDRAZINE | 176848 | 4% | 15% | 22 | Search 1+2+DIMETHYLHYDRAZINE | Search 1+2+DIMETHYLHYDRAZINE |
8 | ABERRANT CRYPT FOCUS | 137045 | 1% | 50% | 5 | Search ABERRANT+CRYPT+FOCUS | Search ABERRANT+CRYPT+FOCUS |
9 | GRANULOCYTE MARKER PROTEIN | 123343 | 1% | 75% | 3 | Search GRANULOCYTE+MARKER+PROTEIN | Search GRANULOCYTE+MARKER+PROTEIN |
10 | ABERRANT CRYPTS FOCI | 109640 | 0% | 100% | 2 | Search ABERRANT+CRYPTS+FOCI | Search ABERRANT+CRYPTS+FOCI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PRETLOW, TP , PRETLOW, TG , (2005) MUTANT KRAS IN ABERRANT CRYPT FOCI (ACF): INITIATION OF COLORECTAL CANCER?.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1756. ISSUE 2. P. 83-96 | 86 | 64% | 61 |
2 | LOPEZ-CERON, M , PELLISE, M , (2012) BIOLOGY AND DIAGNOSIS OF ABERRANT CRYPT FOCI.COLORECTAL DISEASE. VOL. 14. ISSUE 4. P. E157-E164 | 45 | 79% | 4 |
3 | SUZUI, M , MORIOKA, T , YOSHIMI, N , (2013) COLON PRENEOPLASTIC LESIONS IN ANIMAL MODELS.JOURNAL OF TOXICOLOGIC PATHOLOGY. VOL. 26. ISSUE 4. P. 335-341 | 39 | 83% | 10 |
4 | PERSE, M , CERAR, A , (2011) MORPHOLOGICAL AND MOLECULAR ALTERATIONS IN 1,2 DIMETHYLHYDRAZINE AND AZOXYMETHANE INDUCED COLON CARCINOGENESIS IN RATS.JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. VOL. . ISSUE . P. - | 56 | 56% | 32 |
5 | GUPTA, AK , PRETLOW, TP , SCHOEN, RE , (2007) ABERRANT CRYPT FOCI: WHAT WE KNOW AND WHAT WE NEED TO KNOW.CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. VOL. 5. ISSUE 5. P. 526-533 | 50 | 69% | 25 |
6 | GUPTA, AK , SCHOEN, RE , (2009) ABERRANT CRYPT FOCI: ARE THEY INTERMEDIATE ENDPOINTS OF COLON CARCINOGENESIS IN HUMANS?.CURRENT OPINION IN GASTROENTEROLOGY. VOL. 25. ISSUE 1. P. 59-65 | 38 | 83% | 12 |
7 | FENOGLIO-PREISER, CM , NOFFSINGER, A , (1999) ABERRANT CRYPT FOCI: A REVIEW.TOXICOLOGIC PATHOLOGY. VOL. 27. ISSUE 6. P. 632 -642 | 57 | 63% | 56 |
8 | GLEBOV, OK , RODRIGUEZ, LM , SOBALLE, P , DENOBILE, J , CLIATT, J , NAKAHARA, K , KIRSCH, IR , (2006) GENE EXPRESSION PATTERNS DISTINGUISH COLONOSCOPICALLY ISOLATED HUMAN ABERRRANT CRYPT FOCI FROM NORMAL COLONIC MUCOSA.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 15. ISSUE 11. P. 2253 -2262 | 41 | 66% | 23 |
9 | BIRD, RP , (1995) ROLE OF ABERRANT CRYPT FOCI IN UNDERSTANDING THE PATHOGENESIS OF COLON-CANCER.CANCER LETTERS. VOL. 93. ISSUE 1. P. 55 -71 | 42 | 61% | 404 |
10 | MORI, H , HATA, K , YAMADA, Y , KUNO, T , HARA, A , (2005) SIGNIFICANCE AND ROLE OF EARLY-LESIONS IN EXPERIMENTAL COLORECTAL CARCINOGENESIS.CHEMICO-BIOLOGICAL INTERACTIONS. VOL. 155. ISSUE 1-2. P. 1 -9 | 39 | 68% | 40 |
Classes with closest relation at Level 1 |